(ASND) Ascendis Pharma AS - Performance 28.8% in 12m
ASND performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
20.49%
#18 in Peer-Group
Rel. Strength
73.89%
#2011 in Stock-Universe
Total Return 12m
28.77%
#40 in Peer-Group
Total Return 5y
30.84%
#28 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 179.10 USD |
| 52 Week Low | 112.93 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 65.17 |
| Buy/Sell Signal +-5 | 1.39 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ASND (28.8%) vs XBI (-6.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.92% | 72.5% | 80.4% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-8.48% | -6.85% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.26% | -3.11% | 38.6% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.07% | 32.1% | -2.24% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
6.19% | -6.83% | 5.89% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.6% | 39.2% | -5% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.71% | 54.5% | -7.69% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.98% | 29.3% | 17.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ASND vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ASND
| Total Return (including Dividends) | ASND | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 1.48% | 4.28% | 4.37% |
| 3 Months | 27.47% | 17.36% | 14.09% |
| 12 Months | 28.77% | -6.86% | 13.68% |
| 5 Years | 30.84% | -21.19% | 112.88% |
| Trend Score (consistency of price movement) | ASND | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 15.3% | 13.1% | 83.6% |
| 3 Months | 75.6% | 79.4% | 97.2% |
| 12 Months | 68.9% | -87.1% | 45.7% |
| 5 Years | -7.2% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th53.00 | -2.69% | -2.77% |
| 3 Month | %th58.00 | 8.62% | 11.73% |
| 12 Month | %th80.50 | 38.25% | 13.28% |
| 5 Years | %th86.50 | 66.03% | -38.54% |
FAQs
Does Ascendis Pharma AS (ASND) outperform the market?
Yes,
over the last 12 months ASND made 28.77%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.86%.
Over the last 3 months ASND made 27.47%, while XBI made 17.36%.
Performance Comparison ASND vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ASND vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.9% | -2.9% | 27.9% | 15% |
| US NASDAQ 100 | QQQ | 0.5% | -3.5% | 26.1% | 16% |
| German DAX 40 | DAX | -1.7% | -0.1% | 15% | -5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.2% | -2.1% | 24.2% | 9% |
| Hongkong Hang Seng | HSI | 2.4% | -1.7% | 7.4% | -9% |
| India NIFTY 50 | INDA | 1.4% | 0.7% | 27.3% | 30% |
| Brasil Bovespa | EWZ | 4.1% | -2.4% | 9.6% | 25% |
ASND vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.9% | -2.3% | 23.7% | 5% |
| Consumer Discretionary | XLY | 2% | -1.1% | 36.4% | 13% |
| Consumer Staples | XLP | 3.2% | 1.7% | 28.9% | 21% |
| Energy | XLE | 0.2% | -4.8% | 34.8% | 26% |
| Financial | XLF | 1.9% | -1.6% | 24.5% | 1% |
| Health Care | XLV | 1.4% | 0% | 38.1% | 34% |
| Industrial | XLI | 0.3% | -2.4% | 21.2% | 3% |
| Materials | XLB | 1.1% | -2.9% | 24.7% | 22% |
| Real Estate | XLRE | 2.4% | 1.7% | 28.7% | 17% |
| Technology | XLK | -0.2% | -6.3% | 22.9% | 18% |
| Utilities | XLU | 0.7% | -0.8% | 26.1% | 6% |
| Aerospace & Defense | XAR | -0.2% | -3.2% | 9.3% | -21% |
| Biotech | XBI | -2.1% | -2.8% | 37.8% | 36% |
| Homebuilder | XHB | 0.3% | -7.8% | 33% | 21% |
| Retail | XRT | 1.5% | -0.6% | 34% | 18% |
ASND vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -0.3% | -5.29% | 40.6% | 32% |
| Natural Gas | UNG | 9.4% | 15.7% | 58.9% | 39% |
| Gold | GLD | 2.7% | 1.8% | 12.9% | -11% |
| Silver | SLV | 2.2% | 2.7% | 16.5% | 11% |
| Copper | CPER | -4.9% | -10.3% | 8.5% | 8% |
ASND vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.3% | -0.6% | 32.1% | 31% |
| iShares High Yield Corp. Bond | HYG | 1.7% | -0.1% | 30.9% | 19% |